News
Events
Research
Ways to help
About us
Contact Us
DONATE NOW
EVENTS
ANNUAL BALL
CONTACT US
SIGN UP TO NEWSLETTER
Feb 2017
Trish Foundation contributes to first-ever discovery
Jun 2017
Researchers funded by the Trish Foundation making great progress
Dec 2014
2015 Funding announced
Mar 2015
Investigating new treatment options
Oct 2015
Progress in MS Research Conference
Feb 2016
2016 Round of Funding
Sep 2016
Dr Gu's Incubator Grant announced
Jan 2017
New Research Projects commencing 2017 announced

Reprogramming the immune system

 

Dr Christopher Siatskas is developing new treatments for MS by combining immune regeneration and gene therapy approaches.

Dr Christopher Siatskas, based at Monash University, was awarded a project grant in 2011 supported by the Trish MS Research Foundation. His research aims to do nothing less than permanently eliminate the rogue immune cells which cause the damage in MS. Due to mis-programming at the start of their development in the thymus, these immune cells mistakenly attack myelin proteins in the brain and spinal cord. Dr Siatskas plans to reprogram these cells at this early stage in their life-cycle using gene therapy to stop the autoimmune attack.

Earlier work in this project showed that treatment in the thymus prior to the onset of the disease reduced inflammation and neurological damage. However, testing the approach after clinical symptoms began, as would be the case in humans with MS, slowed symptoms but did not cure disease. Recently, Dr Siatskas completed testing with two different immune target molecules in an attempt to improve the effect on immune cells. While one had only a mild effect, the other was able to suppress disease significantly – after symptoms had begun. 

The most important aspect of the work is that it shows that retraining the immune mechanisms is possible, even once the disease process has begun - the ideal model for the treatment situation seen in people with MS. It has also provided Dr Siatskas and his team with a platform to examine a range of immune target molecules with his gene therapy approach.

Trish Foundation & MS Research Australia Working together to find a cure for MS
Copyright © Trish Multiple Sclerosis Research Foundation. All rights reserved.